Table 2.
Temperature, hematology, and chemistry values (mean ± 1 SD) on days 0, 2 and 5 of the study
| Treatment groups |
||||||||||
| Meloxicam |
Buprenorphine |
Bupivicaine |
Reference range | |||||||
| Parameter | Day 0 | Day 2 | Day 5 | Day 0 | Day 2 | Day 5 | Day 0 | Day 2 | Day 5 | |
| Temperature (ºC) | 38.5 ± 0.6 | 38.6 ± 0.7 | 38.8 ± 0.6 | 39.2 ± 0.3 | 39.2 ± 0.2 | 39.3 ± 0.2 | 39.2 ± 0.5 | 38.6 ± 0.4 | 38.9 ± 0.3 | 38.5–39.5 |
| White blood cells (103/µL) | 4.4 ± 1.0 | 4.5 ± 2.1 | 6.3 ± 1.5 | 2.9 ± 1.9 | 6.5 ± 1.0 | 5.3 ± 1.7 | 5.3 ± 1.7 | 6.8 ± 1.4 | 6.9 ± 1 | 5.2–12.5 |
| Hematocrit (%) | 40 ± 2.54 | 40 ± 4.2 | 35 ± 6.7 | 39 ± 9.4 | 39 ± 6.5 | 37 ± 4.4 | 41 ± 3.6 | 38 ± 5.7 | 39 ± 4.3 | 33–50 |
| Glucose (g/dL) | 145 ± 36 | 102 ± 52 | 117 ± 16 | 140 ± 49 | 96 ± 23 | 115 ± 32 | 108 ± 29 | 114 ± 21 | 85 ± 13 | 75–155 |
| Blood urea nitrogen (mg/dL) | 20 ± 3 | 18 ± 3 | 18 ± 3 | 19 ± 5 | 20 ± 6 | 16 ± 3 | 16 ± 3 | 16 ± 2 | 16 ± 2 | 13–29 |
| Creatinine (mg/dL) | 1.1 ± 0.1 | 1.0 ± 0.2 | 0.9 ± 0.1 | 1.5 ± 0.3 | 0.9 ± 0.1 | 0.9 ± 0.1 | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.8 ± 0.1 | 0.5–2.5 |
| Sodium (mEq/L) | 140 ± 8 | 148 ± 10 | 142 ± 2 | 142 ± 2 | 142 ± 2 | 143 ± 2 | 143 ± 2 | 145 ± 3 | 143 ± 2 | 131–155 |
| Potassium (mEq/L) | 3.9 ± 0.7 | 6.3 ± 2 | 4.1 ± 0.5 | 3.5 ± 0.5 | 5.3 ± 0.6 | 4.5 ± 0.4 | 3.7 ± 0.8 | 3.8 ± 0.6 | 4.8 ± 0.4 | 3.6–6.9 |